A privileged view of NKT cells and peripheral tolerance through the eye
- PMID: 16019670
- DOI: 10.1080/09273940490912371
A privileged view of NKT cells and peripheral tolerance through the eye
Abstract
The eye is an immune-privileged site that uses specialized mechanisms to protect itself from damage and to preserve its visual acuity. Among the mechanisms that contribute to the eye's privileged existence is its ability to induce both local and peripheral tolerance to antigens that may transgress its chambers. Experimentally, antigens that are inoculated into the anterior chamber induce an associated immune deviation of immune lymphocytes from their potential T-helper inflammatory responses to T regulatory cells. The prominent role of a somewhat rare cell called invariant (i)NKT cell in the process of tolerance induced through the anterior chamber-associated immune deviation model, ACAID, has revealed novel biological characteristics for the iNKT cell, as well as novel mechanisms for the induction of tolerance that have not been previously known or considered. The role of the iNKT cell in ACAID and its novel story is discussed in this mini-review.
Similar articles
-
Invariant NKT cells and tolerance.Int Rev Immunol. 2007 Jan-Apr;26(1-2):95-119. doi: 10.1080/08830180601070195. Int Rev Immunol. 2007. PMID: 17454266 Review.
-
Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation.J Leukoc Biol. 2001 May;69(5):741-6. J Leukoc Biol. 2001. PMID: 11358982
-
Induction of immune tolerance: a role for Natural killer T lymphocytes?Liver Int. 2005 Jun;25(3):501-4. doi: 10.1111/j.1478-3231.2005.01147.x. Liver Int. 2005. PMID: 15910485 Review.
-
The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system.J Neuroimmunol. 2004 Aug;153(1-2):40-9. doi: 10.1016/j.jneuroim.2004.04.008. J Neuroimmunol. 2004. PMID: 15265662
-
NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye.J Immunol. 2007 Aug 15;179(4):2215-22. doi: 10.4049/jimmunol.179.4.2215. J Immunol. 2007. PMID: 17675481
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources